|Videos|June 6, 2014

What You Need to Know About Global Oncology Trends

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses emerging trends in the treatment of cancer that specialty pharmacies need to be aware of.

This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Webinar Registration

Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring Novel Mechanisms of Action and New Indications to Inform Clinical and Managed Care Decision-Making

Tuesday, September 8, 2026 | 1:00 & 8:00 PM EDT

Webinar Registration

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

Wednesday, September 9 | Tuesday, September 15 | Wednesday, September 30 at 1:00 PM & 8:00 PM EDT

In-Person Conference

NEIAP Conference 2026

September 11, 2026

Virtual Symposium Registration

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Thursday, September 10, 2026 | 12:10 PM-1:10 PM EDT

Virtual Symposium Registration

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Friday, September 11, 2026 | 7:00 AM – 8:00 AM EDT

Virtual Symposium Registration

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

Friday, September 11, 2026 | 12:10 PM – 1:10 PM EDT

Virtual Event

Directions in Oncology Pharmacy® 2026 Midwest

Saturday, September 19, 2026 | 8:00 AM – 2:00 PM CT

Webinar Registration

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Thursday, September 10 | Tuesday, September 22, 2026 at 1:00 PM and 8:00 PM EDT

Virtual Event

Infectious Disease Day of Education 2026

Thursday, September 24, 2026

Virtual Symposium Registration

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

Friday, October 2, 2026 | 1:00 PM – 2:30 PM EDT

Webinar Registration

Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management

Thursday October 8, 2026 | 1:00 PM & 8:00 PM EDT

Webinar Registration

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Webinar Registration

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

What You Need to Know About Global Oncology Trends

Related Content

Consensus Study Sets Standard Outcomes for CKD Pharmacist Trials

How UPMC's Integrated Model Supports Members With Multiple Sclerosis

Beyond GLP-1: Amylin, Glucagon Enter Obesity Care

What Every Oncology Pharmacist Should Know About Gynecologic Cancer This September

Injection Technique to Oral Dosing: Obesity Rx Tips

Latest CME

Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring Novel Mechanisms of Action and New Indications to Inform Clinical and Managed Care Decision-Making

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

NEIAP Conference 2026

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

Directions in Oncology Pharmacy® 2026 Midwest

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Infectious Disease Day of Education 2026

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

Hat Trick for Hypertension: Strategies to Improve Outcomes With Single-Pill Combinations

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Stop and Smell the ROSis: Translating Molecular Results Into Actionable Pharmacy Practice in ROS1-Rearranged NSCLC

Navigating Outpatient Bispecific Antibody Administration in Lymphoma: Practical Solutions for Community Oncology Practices

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Infectious Disease Day of Education 2026

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

PBMI 2026

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Directions in Oncology Pharmacy® 2026 West Coast

Lung Cancer Day of Education 2026

ASCP 2026

Exploring Immunotherapy Strategies in Endometrial Cancer

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)